Cargando…
Metformin in the management of fibrocystic breast disease: a placebo-controlled randomized clinical trial
BACKGROUND AND PURPOSE: Fibrocystic disease (FCD) of the breast as a very common health problem in women has estrogen-dependent and proliferative features. No effective management strategy has been validated for this disorder, so far. The anti-hyperglycemic agent metformin has both anti-proliferativ...
Autores principales: | Alipour, Sadaf, Rastad, Hadith, Saberi, Azin, Faiz, Firoozeh, Maleki-Hajiagha, Arezoo, Abedi, Mahboubeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557102/ https://www.ncbi.nlm.nih.gov/pubmed/34719004 http://dx.doi.org/10.1007/s40199-021-00424-6 |
Ejemplares similares
-
Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial
por: Alipour, Sadaf, et al.
Publicado: (2021) -
Infertility Does Not Increase the Rate of Breast Fibroadenoma
por: Motamedi, Mandana, et al.
Publicado: (2023) -
The association of metformin and aspirin intake with mammographic breast density: A cross-sectional study
por: Eslami, Bita, et al.
Publicado: (2023) -
Elmslie and Fibrocystic Disease of Bone
por: Stiles, P. J.
Publicado: (1966) -
SENSITIZATION TO ASPERGILLUS FUMIGATUS IN
FIBROCYSTICS
por: Rosario, Nelson A., et al.
Publicado: (2018)